LON:AKR Akers Biosciences (AKR) Share Price, News & Analysis → The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad) Free AKR Stock Alerts GBX 57.50 0.00 (0.00%) (As of 03/28/2019) Add Compare Share Share Today's Range 57.50▼ 57.5050-Day Range 57.50▼ 57.5052-Week Range 23.50▼ 491.60Volume262 shsAverage Volume818 shsMarket Capitalization£21.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Akers Biosciences alerts: Email Address Ad Porter & CompanyThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technology as well. In my new investigation, I detail why this technology is the single biggest breakthrough of the decade.Click here to watch it now. About Akers Biosciences Stock (LON:AKR)Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States, the People's Republic of China, and internationally. The company's marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness. Its marketed products also include PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests for Heparin/PF4 antibodies to detect an allergy to the used blood thinner, Heparin; seraSTAT, a rapid blood cell separator; Tri-Cholesterol 'Check', a rapid test for total and high density lipoprotein cholesterol and estimates low density lipo protein; and BreathScan OxiCHek, a breath test for oxidative stress using the Lync reader and digital app. The company's pipeline products comprise Breath Diabetic Ketoacidosis, a disposable breath ketone device for diabetic monitoring; Breath PulmoHealth 'Check', a suite of breath tests for biomarkers indicating asthma, chronic obstructive pulmonary disease, and lung cancer; PIFA PLUSS Chlamydia, a rapid test for sexually transmitted diseases; and BreathScan KetoChek, a breath test for ketosis using the Lync reader and digital app. Akers Biosciences, Inc. was founded in 1989 and is headquartered in Thorofare, New Jersey.Read More AKR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AKR Stock News HeadlinesMay 18, 2024 | msn.comCam Akers Possibly Working Toward A ReturnApril 21, 2024 | finance.yahoo.comCan Ackroo Inc. (CVE:AKR) Maintain Its Strong Returns?February 10, 2024 | health.usnews.comMary K. AkersFebruary 9, 2024 | health.usnews.comKristin K. AkersJanuary 23, 2024 | morningstar.comPT AKR Corporindo TbkNovember 6, 2023 | msn.comVikings RB Cam Akers reportedly tore his Achilles in win over FalconsNovember 6, 2023 | msn.comMRI confirms Vikings running back Cam Akers suffered torn AchillesNovember 6, 2023 | msn.comVikings Injury Updates: Cam Akers, Christian Darrisaw, T.J. HockensonNovember 6, 2023 | msn.comVikings RB Cam Akers has torn Achilles, MRI confirmsNovember 5, 2023 | msn.comVikings RB Cam Akers feared to have sustained Achilles injury in win over FalconsOctober 7, 2023 | duluthnewstribune.comVikings running back Cam Akers is all about words of affirmation. Just ask his teammates in the huddleSeptember 22, 2023 | msn.comCam Akers likely won’t play for Vikings on Sunday. He’s still excited for the fresh start.September 22, 2023 | sports.yahoo.comWhere does Cam Akers fit in the Vikings' depth chart?September 21, 2023 | msn.comRB Cam Akers passes physical, trade to Vikings officialSeptember 21, 2023 | health.usnews.comJeremy AkersSeptember 21, 2023 | msn.comCompensation for Cam Akers trade revealedSeptember 20, 2023 | msn.comFamiliarity should help Cam Akers' transition with VikingsAugust 17, 2023 | seekingalpha.comRENB Enochian Biosciences Inc.July 25, 2023 | sports.yahoo.comCam Akers acknowledges this is a big season: I know what's at stake hereJuly 24, 2023 | wsj.comAKR CorporindoJune 8, 2023 | health.usnews.comLaura L. AkersFebruary 10, 2023 | investing.comAkr Corporindo Tbk (AKRA)October 18, 2022 | ftw.usatoday.comFantasy football Week 6 injury report: Take Cam Akers and James Conner out of your lineupsSeptember 15, 2022 | yahoo.comCam Akers was surprised by Week 1 role, will learn from Sean McVay’s request for more urgencyJune 14, 2022 | yahoo.comFantasy outlook: Analyzing Cam Akers’ value in dynasty leaguesSee More Headlines Receive AKR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolLON:AKR CUSIPN/A CIKN/A Webwww.akersbio.com Phone+1-856-8488698FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.44 Quick Ratio2.83 Sales & Book Value Annual Sales£2.32 million Price / Sales9.31 Cash FlowGBX 63.76 per share Price / Cash Flow0.90 Book ValueGBX 65.50 per share Price / Book0.88Miscellaneous Outstanding Shares37,640,000Free FloatN/AMarket Cap£21.64 million OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Gary M. Rauch (Age 63)VP of Fin. & Treasurer Mr. Howard R. Yeaton Jr. (Age 64)CPA, CEO & Interim CFO Mr. Douglas CarraraSr. VP of Global Marketing & Commercial OperationsMs. Pamela E. HiblerVP of Sales & DistributionKey CompetitorsBATM Advanced CommunicationsLON:BVCINSPECS GroupLON:SPECCambridge Nutritional SciencesLON:CNSLOmega Diagnostics GroupLON:ODXConvaTec GroupLON:CTECView All Competitors AKR Stock Analysis - Frequently Asked Questions How have AKR shares performed in 2024? Akers Biosciences' stock was trading at GBX 57.50 at the start of the year. Since then, AKR shares have increased by 0.0% and is now trading at GBX 57.50. View the best growth stocks for 2024 here. What other stocks do shareholders of Akers Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Akers Biosciences investors own include SandRidge Permian Trust (PER), Rite Aid (RAD), AT&T (T), BP (BP), Cross Timbers Royalty Trust (CRT), Solbright Group (SBRT), Broadcom (AVGO), Achillion Pharmaceuticals (ACHN), Akamai Technologies (AKAM) and Akorn (AKRX). How do I buy shares of Akers Biosciences? Shares of AKR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AKR) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akers Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.